The Effect Of Risk Factors And Clinical Symptoms On Comorbid And Non-Comorbid Disease In Covid-19 Patients At Royal Prima General Hospital Medan

Authors

  • Putri Gly De La Glory Ginting Program Study Master Of Public Health Faculty Of Medicine, Dentaland Health Science, University Prima Indonesia
  • Marlinang Isabela Silalahi Program Study Master Of Public Health Faculty Of Medicine, Dentaland Health Science, University Prima Indonesia
  • Sri Lestari Nasution Program Study Master Of Public Health Faculty Of Medicine, Dentaland Health Science, University Prima Indonesia

DOI:

https://doi.org/10.51601/ijhp.v2i2.52

Abstract

Covid-19 is a disease caused by infection with SARS-CoV-2 and causes a variety of clinical symptoms ranging from asymptomatic to critical symptoms, depending on various risk factors. The purpose of this research is to analyze the effect of risk factors (age, gender, occupation) and clinical symptoms (asymptomatic, mild, moderate, severe, critical) on comorbid and non-comorbid diseases in Covid-19 patients at General Hospital Royal Prima Medan. This Paper research used is quantitative research with secondary data collection in April-June 2021. The number of research samples was 308 comorbid patients and 308 non-comorbid patients. Data were analyzed univariately to see a descriptive picture, bivariate using chi-square test, and multivariate using binary logistic regression test. The results of this study are: based on age risk factors, the highest age group is 46-65 years (40.1%). The conclusions in this study are there is an influence of risk factors for age, gender, and mild, moderate, and severe clinical symptoms on comorbid and non-comorbid diseases in Covid-19 patients at Royal Prima Hospital Medan.

References

Arikunto, S. (2016). Research Procedure: A Practical Approach. Rineka Cipta.

Burhan et al. (2020). COVID-19 MANAGEMENT GUIDELINES (1st ed.). PDPI, PERKI, PAPDI, PERDATIN, IDAI.

Cai, H. (2020). Sex difference and smoking predisposition in patients with COVID-19. The Lancet Respiratory Medicine, 8(4), e20. https://doi.org/10.1016/S2213-2600(20)30117-X

Chan JF, To KK, Tse H, Jin DY, YK (2013). Interspecies transmission and emergence of novel viruses: lessons from bats and birds. 21(10), 544–555.

Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/10.1002/jmv.25681

Escalera-Antezana, JP, Lizon-Ferrufino, NF, Maldonado-Alanoca, A., Alarcón-De-la-vega, G., Alvarado-Arnez, LE, Balderrama-Saavedra, MA, Katterine Bonilla-Aldana, D., & Rodríguez-Morales, AJ (2020). Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases. Infezioni in Medicina, 28(2), 238–242.

Fang, L., Karakiulakis, G., & Roth, M. (2020). Antihypertensive drugs and risk of COVID-19? – Authors' replies. The Lancet Respiratory Medicine, 8(5), e32–e33. https://doi.org/10.1016/S2213-2600(20)30159-4

Guan, W. et al. (2020a). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/10.1056/nejmoa2002032

Guan, W. et al. (2020b). Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis Wei-jie. Eur Respira J, 1–4. https://doi.org/10.1183/13993003.00547-2020

Hidayani, WR (2020). Risk Factors Associated with COVID 19 : Literature Review. Journal for Healthy Society (JUKMAS), 4(2), 120–134. http://ejournal.urindo.ac.id/index.php/jukmas%0AArticle

Hudari, H. (2020). Covid-19 diagnosis. Unsri RSMH Palembang.

Ikawaty, R. (2020). Dynamics of Interaction of ACE2 Receptors and SARS-CoV-2 Against Clinical Manifestations of COVID-19. KELUWIH: Journal of Health and Medicine, 1(2), 70–76. https://doi.org/10.24123/kesdok.v1i2.2869

Isabiah et al. (2020). Guidelines for Preparedness for Coronavirus Disease (COVID-19). In Ministry of Health, Republic of Indonesia Directorate General, Disease Prevention and Control (P2P) (pp. 0–115).

Jakovljević, M., & Ostojić, L. (2013). Comorbidity and multimorbidity in medicine today: challenges and opportunities for bringing separated branches of medicine closer to each other. In Psychiatria Danubina: Vol. 25 Suppl 1 (pp. 18–28).

Ministry of Health, R. (2021). Latest Situation of the Development of Coronavirus Disease (COVID-19) 02 March 2021. https://covid19.kemkes.go.id/situasi-infection-emerging/situasi-terkini-perkembangan-coronavirus-disease-covid-19-02-maret- 2021

Liu, W., Tao, ZW, Wang, L., Yuan, ML, Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, HG, Yang, M. ., & Hu, Y. (2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal, 133(9), 1032–1038. https://doi.org/10.1097/CM9.0000000000000775

Liu, Y., Gayle, AA, Wilder-Smith, A., & Rocklöv, J. (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine, 27(2), 1–4. https://doi.org/10.1093/jtm/taaa021

Longato, E., Di Camillo, B., Sparacino, G., Gubian, L., Avogaro, A., & Fadini, GP (2020). Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life. BMJ Open Diabetes Research & Care, 8(1). https://doi.org/10.2766/bmjdrc-2020-001451

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., … Tan, W. (2020). Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565–574. https://doi.org/10.1016/S0140-6736(20)30251-8

Mehta, P., McAuley, DF, Brown, M., Sanchez, E., Tattersall, RS, & Manson, JJ (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet, 395(10229), 1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0

Nursastri, SA (2020). Covid-19 Risk Factors, from Age to Congenital Diseases. https://doi.org/https://www.kompas.com/sains/read/2020/04/13/200200423/risk-factors-covid-19-dari-age-to-disease-congenital?page= all

Okay, J., & Heneghan, C. (2020). Global Covid-19 Case Fatality Rates. https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates. OXFORD CEBM Research, 1–12. https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/

Salehi, S., Abedi, A., Balakrishnan, S., & Gholamrezanezhad, A. (2020). Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. American Journal of Roentgenology, 215(1), 87–93. https://doi.org/10.2214/AJR.20.23034

Satria, RMA, Tutupoho, RV, & Chalidyanto, D. (2020). Analysis of Risk Factors for Death with Comorbid Covid-19 Diseases. Silampari Journal of Nursing, 4(1), 48–55. https://doi.org/10.31539/jks.v4i1.1587

Sugiyono. (2017). Research Methods Quantitative, Qualitative and R&D. Alphabet.

Sulandjari R., Kusumawardani Y., FD (2021). Socialization of the manufacture of hand sanitizers (HS) and distribution in the community around Pandanaran University. 6(12), 42–64.

The Lancet. (2020). The gendered dimensions of COVID-19 Suhaimi. 395(10231), 1168. https://www.thelancet.com/

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. CCDC Weekly, 2(x), 1–10. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003

Thevarajan, et al. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450–452. https://doi.org/10.1038/s41591-020-0820-9

Valderas, JM, Starfi, B., & Sibbald, B. (2009). Understanding Health and Health Services. Annals Of Family Medicine, 357–363. https://doi.org/10.1370/afm.983.Martin

Wan, Y., Shang, J., Graham, R., Baric, RS, & Li, F. (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology, 94(7), 1–9. https://doi.org/10.1128/jvi.00127-20

Wang, Z., Qiang, W., Ke, H. (2020). A Handbook of 2019-nCoV Pneumonia Control and Prevention. Hubei Science and Technology Press.

Wang et al. (2020). Does comorbidity increase the risk of patients with COVID-19. Aging, 12(7), 6049–6057.

Wang, J., Zhou, M., & Liu, F. (2020). Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. Journal of Hospital Infection, 105(1), 100–101. https://doi.org/10.1016/j.jhin.2020.03.002

Welle., D. (2020). What Affects the High Ratio of Deaths Due to Corona in Indonesia? https://news.detik.com/dw/d-4947076/apa-saja-yang-meunjuki-high-ratio-kematian-hasil-corona-di-ri

WHO. (2020a). Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public

WHO. (2020b). Coronavirus disease 2019 (COVID-19) Situation Report -51. World Health Organization.

WHO. (2020c). Coronavirus disease 2019 (COVID-19) Situation Report – 68. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

WHO. (2020d). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19).

WHO. (2021a). COVID-19 Weekly Epidemiological Update 22. https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf

WHO. (2021b). Global Situation ; Situation by Country, Territory & Area. https://covid19.who.int/?gclid=EAIaIQobChMIw7C5oqi27wIVUddMAh1OlQKPEAAYASABEgJFz_D_BwE

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., … Song, Y. (2020). Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934–943. https://doi.org/10.1001/jammainternmed.2020.0994

Downloads

Published

2022-05-26

How to Cite

Gly De La Glory Ginting, P. ., Isabela Silalahi, M. ., & Lestari Nasution, S. . (2022). The Effect Of Risk Factors And Clinical Symptoms On Comorbid And Non-Comorbid Disease In Covid-19 Patients At Royal Prima General Hospital Medan. International Journal of Health and Pharmaceutical (IJHP), 2(2), 404–413. https://doi.org/10.51601/ijhp.v2i2.52

Issue

Section

Articles

Most read articles by the same author(s)